For Doctors Emergency Care Medikoe LogoDr Specialisation
Book AppointmentHealth HubMedicommunity
Home > Health Hub > Article > What medications are currently approved to treat COVID-19?

What medications are currently approved to treat COVID-19?

Medikoe Health Expert

Medikoe Health Expert

  Koramangala, bengaluru, karnataka, india, Bengaluru     Jun 30, 2021

   2 min     

undefined

Overview

While almost all people who contract COVID-19 are able to improve at home, the haste is on to find a treatment that is safe and powerful against severe, life-threatening cases of the infection.

Specialists in hospitals and laboratories across the globe are carrying hundreds of investigations exploring whether various medications can help us with COVID-19 or not? 

Government-approved medications for covid-19

The government is watching over the supply of various essential drugs used to treat the Covid-19 infection. In an official statement, all the drugs used in the management of Covid-19 were noted that are now available in India by ramping up production and increasing imports.

Protocol drugs approved by the government are:

  • Remdesivir
  • MethylPrednisolone
  • Enoxaparin
  • Dexamethasone
  • Ivermectin
  • Tocilizumab

Non-protocol drugs include:

  • Amphotericin
  • Favipiravir  
  • Apixaban

Vaccines for covid-19

Scientists throughout the world are developing multiple potential vaccines for coronavirus infection. These vaccines are all created to teach the body's immune system to safely recognise and restrict the virus that causes COVID-19. Several different kinds of vaccines for COVID-19 are available, including:

Covaxin

Covaxin is an inactivated viral vaccine. It is developed with Whole-Virion Inactivated Vero Cell-derived technology. These contain inactivated viruses, which can not infect a person; however, they can still teach your immune system to build a defence mechanism against the live virus.

These common vaccines have been in use for years now. The second dose of Covaxin is scheduled following 4-6 weeks after the first dose.

Covishield

Covishield is developed using the viral vector platform. It contains a  chimpanzee adenovirus – ChAdOx1 – that has been altered and transformed to allow it to carry the COVID-19 spike protein into the human cells. Well, this cold virus is radically incapable of infecting the subject but can very well influence your immune system to develop a mechanism against such viral infections. The second dose of covishield vaccines is scheduled for 12-16 weeks or 84 days after the first dose.

Sputnik V  

The Russian COVID-19 vaccine Sputnik V – Gam-COVID-Vac – is an adenoviral-based, two-part vaccine to fight the SARS-CoV-2 coronavirus. Originally developed in Russia, Sputnik V utilises a weakened virus to deliver tiny parts of a pathogen and incite an immune response.

Sputnik V is a vector vaccine formulated as per the adenovirus DNA, in which the SARS-CoV-2 coronavirus gene is integrated. 

Medikoe is an online platform that allows you to search and connect with the most qualified and experienced doctors near you. Have a query related to Health? Get it answered for free within 24 hours only at Medikoe. Download Medikoe'sMedikoe's Mobile app and book an appointment with a doctor for free.

Tags:  virus,viral infection,virus infection,bacterial infections,Allergies and Infections,Medicines,Meditation,vaccination,COVID-19, medications for covid-19, Remdesivir, Covid-19 infection, Vaccines for covid-19, covaxin, covisheild, sputnik v, SARS-CoV-2 coronavirus

Note: We at Medikoe provide you with the best healthcare articles written and endorsed by experts of the healthcare industry to boost you knowledge. However, we strongly recommend that users consult a doctor or concerned service provider for expert diagnosis before acting on this information.

  0 Likes |    0 Comments |    0 Share |    68 Views
COMMENTS